174 related articles for article (PubMed ID: 24374419)
1. Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients.
Warren JL; Mariotto A; Melbert D; Schrag D; Doria-Rose P; Penson D; Yabroff KR
Med Care; 2016 Aug; 54(8):e47-54. PubMed ID: 24374419
[TBL] [Abstract][Full Text] [Related]
2. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
3. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Gold HT; Do HT
Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
[TBL] [Abstract][Full Text] [Related]
5. Utility of the SEER-Medicare data to identify chemotherapy use.
Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
[TBL] [Abstract][Full Text] [Related]
6. Using Medicare claims to identify second primary cancers and recurrences in order to supplement a cancer registry.
McClish D; Penberthy L; Pugh A
J Clin Epidemiol; 2003 Aug; 56(8):760-7. PubMed ID: 12954468
[TBL] [Abstract][Full Text] [Related]
7. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s.
Kim SP; Feinglass J; Bennett CL; Lyons T; Simon C; Weinberg MN; Talamonti MS
Cancer Invest; 2004; 22(2):225-33. PubMed ID: 15199605
[TBL] [Abstract][Full Text] [Related]
8. Costs of breast cancer recurrence after initial treatment for HR+, HER2-, high-risk early breast cancer: estimates from SEER-Medicare linked data.
Vitko AS; Martin P; Zhang S; Johnston A; Ohsfeldt R; Zheng S; Liepa AM
J Med Econ; 2024; 27(1):84-96. PubMed ID: 38059275
[TBL] [Abstract][Full Text] [Related]
9. Potentially inappropriate medication use in older patients with breast and colorectal cancer.
Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
Cancer; 2018 Jul; 124(14):3000-3007. PubMed ID: 29689595
[TBL] [Abstract][Full Text] [Related]
10. Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography.
Fenton JJ; Onega T; Zhu W; Balch S; Smith-Bindman R; Henderson L; Sprague BL; Kerlikowske K; Hubbard RA
Med Care; 2016 Mar; 54(3):e15-22. PubMed ID: 23929404
[TBL] [Abstract][Full Text] [Related]
11. The utility of Medicare claims data for measuring cancer stage.
Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
[TBL] [Abstract][Full Text] [Related]
12. Development of a claims-based algorithm to identify colorectal cancer recurrence.
Deshpande AD; Schootman M; Mayer A
Ann Epidemiol; 2015 Apr; 25(4):297-300. PubMed ID: 25794767
[TBL] [Abstract][Full Text] [Related]
13. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.
Hassett MJ; Ritzwoller DP; Taback N; Carroll N; Cronin AM; Ting GV; Schrag D; Warren JL; Hornbrook MC; Weeks JC
Med Care; 2014 Oct; 52(10):e65-73. PubMed ID: 23222531
[TBL] [Abstract][Full Text] [Related]
14. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
[TBL] [Abstract][Full Text] [Related]
15. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?
Keating NL; Landrum MB; Meara E; Ganz PA; Guadagnoli E
J Natl Cancer Inst; 2005 Feb; 97(4):257-64. PubMed ID: 15713960
[TBL] [Abstract][Full Text] [Related]
16. Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS
Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166
[TBL] [Abstract][Full Text] [Related]
17. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
Brown ML; Riley GF; Potosky AL; Etzioni RD
Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
[TBL] [Abstract][Full Text] [Related]
18. Development of a Machine Learning Model to Identify Colorectal Cancer Stage in Medicare Claims.
Finn CB; Sharpe JE; Tong JK; Kaufman EJ; Wachtel H; Aarons CB; Weissman GE; Kelz RR
JCO Clin Cancer Inform; 2023 May; 7():e2300003. PubMed ID: 37257142
[TBL] [Abstract][Full Text] [Related]
19. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
20. Surveillance mammography for Medicaid/Medicare breast cancer patients.
Carcaise-Edinboro P; Bradley CJ; Dahman B
J Cancer Surviv; 2010 Mar; 4(1):59-66. PubMed ID: 20091247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
